Wells Fargo
EXAS

Wells Fargo’s Exact Sciences EXAS Stock Holding History

Wells Fargo’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,183
Closed -$5.3M – 7275
2025
Q4 		$5.3M Sell
52,183
-51,689
-50% -$4.15M ﹤0.01% 2625
2025
Q3 		$5.68M Sell
103,872
-14,167
-12% -$708K ﹤0.01% 2461
2025
Q2 		$6.27M Sell
118,039
-19,291
-14% -$980K ﹤0.01% 2294
2025
Q1 		$5.94M Buy
137,330
+10,303
+8% +$522K ﹤0.01% 2256
2024
Q4 		$7.14M Sell
127,027
-19,167
-13% -$1.19M ﹤0.01% 2161
2024
Q3 		$9.96M Buy
146,194
+2,612
+2% +$147K ﹤0.01% 1838
2024
Q2 		$6.07M Sell
143,582
-151,281
-51% -$8.32M ﹤0.01% 2113
2024
Q1 		$20.4M Sell
294,863
-46,119
-14% -$2.92M ﹤0.01% 1223
2023
Q4 		$25.2M Sell
340,982
-91,353
-21% -$5.99M 0.01% 1033
2023
Q3 		$29.5M Buy
432,335
+51,030
+13% +$4.33M 0.01% 903
2023
Q2 		$35.8M Buy
381,305
+10,240
+3% +$799K 0.01% 837
2023
Q1 		$25.2M Buy
371,065
+99,554
+37% +$6.4M 0.01% 996
2022
Q4 		$13.4M Sell
271,511
-4,976
-2% -$203K ﹤0.01% 1359
2022
Q3 		$8.98M Buy
276,487
+19,904
+8% +$821K ﹤0.01% 1597
2022
Q2 		$10.1M Buy
256,583
+17,310
+7% +$926K ﹤0.01% 1565
2022
Q1 		$16.7M Buy
239,273
+70,402
+42% +$5.15M ﹤0.01% 1435
2021
Q4 		$13.1M Sell
168,871
-56,313
-25% -$4.97M ﹤0.01% 1640
2021
Q3 		$21.5M Sell
225,184
-26,719
-11% -$2.82M ﹤0.01% 1600
2021
Q2 		$31.3M Sell
251,903
-65,532
-21% -$7.82M 0.01% 1374
2021
Q1 		$41.8M Sell
317,435
-1,667,154
-84% -$228M 0.01% 1146
2020
Q4 		$263M Sell
1,984,589
-284,843
-13% -$34.4M 0.06% 295
2020
Q3 		$231M Sell
2,269,432
-979,061
-30% -$84.6M 0.06% 292
2020
Q2 		$282M Buy
3,248,493
+227,010
+8% +$18.1M 0.08% 238
2020
Q1 		$175M Buy
3,021,483
+904,983
+43% +$73.5M 0.06% 300
2019
Q4 		$196M Buy
2,116,500
+783,218
+59% +$68.9M 0.05% 354
2019
Q3 		$120M Sell
1,333,282
-26,837
-2% -$3.06M 0.03% 492
2019
Q2 		$161M Sell
1,360,119
-62,239
-4% -$6.27M 0.05% 401
2019
Q1 		$123M Buy
1,422,358
+390,268
+38% +$33.2M 0.04% 468
2018
Q4 		$65.1M Buy
1,032,090
+232,977
+29% +$16M 0.02% 690
2018
Q3 		$63.1M Buy
799,113
+635,473
+388% +$41.4M 0.02% 805
2018
Q2 		$9.78M Sell
163,640
-114,059
-41% -$6.14M ﹤0.01% 2098
2018
Q1 		$11.2M Sell
277,699
-190,685
-41% -$9.3M ﹤0.01% 1912
2017
Q4 		$24.6M Sell
468,384
-95,833
-17% -$5.12M 0.01% 1325
2017
Q3 		$26.6M Buy
564,217
+66,555
+13% +$2.68M 0.01% 1242
2017
Q2 		$17.6M Buy
497,662
+185,230
+59% +$5.72M 0.01% 1474
2017
Q1 		$7.38M Buy
312,432
+101,841
+48% +$2.02M ﹤0.01% 2120
2016
Q4 		$2.81M Buy
210,591
+48,093
+30% +$776K ﹤0.01% 2879
2016
Q3 		$3.02M Buy
162,498
+33,500
+26% +$590K ﹤0.01% 2649
2016
Q2 		$1.58M Sell
128,998
-25,823
-17% -$194K ﹤0.01% 3150
2016
Q1 		$1.04M Sell
154,821
-250,025
-62% -$1.6M ﹤0.01% 3387
2015
Q4 		$3.74M Sell
404,846
-1,012,920
-71% -$9.42M ﹤0.01% 2536
2015
Q3 		$25.5M Buy
1,417,766
+213,811
+18% +$4.91M 0.01% 1137
2015
Q2 		$35.8M Buy
1,203,955
+107,521
+10% +$2.7M 0.01% 985
2015
Q1 		$24.1M Buy
1,096,434
+296,199
+37% +$7.51M 0.01% 1206
2014
Q4 		$22M Sell
800,235
-51,276
-6% -$1.25M 0.01% 1221
2014
Q3 		$16.5M Sell
851,511
-186,576
-18% -$3.42M 0.01% 1385
2014
Q2 		$17.7M Sell
1,038,087
-34,531
-3% -$475K 0.01% 1380
2014
Q1 		$15.2M Buy
1,072,618
+49,742
+5% +$672K 0.01% 1461
2013
Q4 		$12M Sell
1,022,876
-62,558
-6% -$718K 0.01% 1591
2013
Q3 		$12.8M Sell
1,085,434
-9,635
-0.9% -$124K 0.01% 1480
2013
Q2 		$15.2M Buy
+1,095,069
New +$11.9M 0.01% 1306

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Wells Fargo's EXAS Position: Q1 2026 in Review

Wells Fargo sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 52,183 shares — an estimated $5.3M sold.

Wells Fargo first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $282M in Q2 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Wells Fargo reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 52,183 Exact Sciences shares in Q1 2026, an estimated $5.3M.
  • Wells Fargo first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Wells Fargo's Exact Sciences position peaked at $282M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.